Literature DB >> 19074372

The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges.

David R Greaves1, Siamon Gordon.   

Abstract

It is now thirty years since the original observation that macrophages take up and degrade modified forms of low density lipoprotein (LDL). Molecular cloning has identified multiple scavenger receptors that can endocytose modified LDL and binding studies continue to identify a wide range of scavenger receptor ligands displayed by bacterial pathogens, modified self proteins and apoptotic cells. Scavenger receptors drive macrophage foam cell development in vitro but their exact role in the development of atherosclerosis remains difficult to assess critically. This could be due in part to functional redundancy or it could perhaps reflect our incomplete appreciation of all the potential roles of this family of receptors in host defense and tissue homeostasis. In this brief overview of the extensive literature in this area we emphasize the continuing duality of scavenger receptors as sensors of both nonself (pathogens) and modified self (modified forms of LDL and apoptotic cells). We highlight some under-appreciated roles of scavenger receptors in macrophage biology (e.g., regulation of macrophage cytokine responses) and we speculate on potential approaches to target the activity of this diverse family of receptors for therapeutic benefit in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074372      PMCID: PMC2674758          DOI: 10.1194/jlr.R800066-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

1.  Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Authors:  Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

2.  Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime.

Authors:  Daniel Steinberg
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

3.  Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages.

Authors:  Michael Khan; Stella Pelengaris; Michael Cooper; Chris Smith; Gerard Evan; John Betteridge
Journal:  Atherosclerosis       Date:  2003-11       Impact factor: 5.162

Review 4.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

5.  Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.

Authors:  Mohamad Navab; G M Anantharamaiah; Susan Hama; David W Garber; Manjula Chaddha; Greg Hough; Roger Lallone; Alan M Fogelman
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

6.  CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart.

Authors:  V Bodart; M Febbraio; A Demers; N McNicoll; P Pohankova; A Perreault; T Sejlitz; E Escher; R L Silverstein; D Lamontagne; H Ong
Journal:  Circ Res       Date:  2002-05-03       Impact factor: 17.367

7.  Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.

Authors:  Mohamad Navab; G M Anantharamaiah; Srinivasa T Reddy; Susan Hama; Greg Hough; Victor R Grijalva; Alan C Wagner; Joy S Frank; Geeta Datta; David Garber; Alan M Fogelman
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

8.  Evasion of macrophage scavenger receptor A-mediated recognition by pathogenic streptococci.

Authors:  Thomas Areschoug; Johan Waldemarsson; Siamon Gordon
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

9.  Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.

Authors:  Brian J Van Lenten; Alan C Wagner; G M Anantharamaiah; David W Garber; Michael C Fishbein; Lopa Adhikary; Debi P Nayak; Susan Hama; Mohamad Navab; Alan M Fogelman
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

10.  Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis.

Authors:  C A Thomas; Y Li; T Kodama; H Suzuki; S C Silverstein; J El Khoury
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

View more
  80 in total

1.  Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury.

Authors:  Chen Lu; Fang Hua; Li Liu; Tuanzhu Ha; John Kalbfleisch; John Schweitzer; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

2.  COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells.

Authors:  Kamran Anwar; Iryna Voloshyna; Michael J Littlefield; Steven E Carsons; Peter A Wirkowski; Nadia L Jaber; Andrew Sohn; Sajan Eapen; Allison B Reiss
Journal:  Lipids       Date:  2010-12-22       Impact factor: 1.880

Review 3.  Atherosclerosis: current pathogenesis and therapeutic options.

Authors:  Christian Weber; Heidi Noels
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 4.  Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Authors:  Tuanzhu Ha; Li Liu; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

5.  Scientific side trips: six excursions from the beaten path.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

Review 6.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

7.  Multimodality PET/MRI agents targeted to activated macrophages.

Authors:  Chuqiao Tu; Thomas S C Ng; Russell E Jacobs; Angelique Y Louie
Journal:  J Biol Inorg Chem       Date:  2013-10-29       Impact factor: 3.358

Review 8.  The immune system in atherosclerosis.

Authors:  Göran K Hansson; Andreas Hermansson
Journal:  Nat Immunol       Date:  2011-03       Impact factor: 25.606

Review 9.  The macrophage: the intersection between HIV infection and atherosclerosis.

Authors:  Suzanne M Crowe; Clare L V Westhorpe; Nigora Mukhamedova; Anthony Jaworowski; Dmitri Sviridov; Michael Bukrinsky
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

10.  Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

Authors:  Dennis Montoya; Daniel Cruz; Rosane M B Teles; Delphine J Lee; Maria Teresa Ochoa; Stephan R Krutzik; Rene Chun; Mirjam Schenk; Xiaoran Zhang; Benjamin G Ferguson; Anne E Burdick; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Genhong Cheng; Robert L Modlin
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.